Structure–activity relationships study of mTOR kinase inhibition using QSAR and structure-based drug design approaches

References

• MurakamiMIchisakaTMaedaMmTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cellsMol Cell Biol200424156710671815254238
   PubMed Web of Science ®Google Scholar
• RichardDJVerheijenJCZaskARecent advances in the development of selective, ATP-competitive inhibitors of mTORCurr Opin Drug Discov Devel2010134428440
   PubMed Web of Science ®Google Scholar
• ZhangY-JDuanYZhengXFSTargeting the mTOR kinase domain: the second generation of mTOR inhibitorsDrug Discov Today2011167–832533121333749
   PubMed Web of Science ®Google Scholar
• LePTChengHNinkovicSDesign and synthesis of a novel pyrrolidinyl pyrido pyrimidinone derivative as a potent inhibitor of PI3Kα and mTORBioorg Med Chem Lett201222155098510322749419
   PubMed Web of Science ®Google Scholar
• PetersonEABoezioAAAndrewsPSDiscovery and optimization of potent and selective imidazopyridine and imidazopyridazine mTOR inhibitorsBioorg Med Chem Lett201222154967497422765895
   PubMed Web of Science ®Google Scholar
• LiuKKCHuangXBagrodiaSQuinazolines with intra-molecular hydrogen bonding scaffold (iMHBS) as PI3K/mTOR dual inhibitorsBioorg Med Chem Lett20112141270127421269826
   PubMed Web of Science ®Google Scholar
• LeeWOrtwineDFBergeronPA hit to lead discovery of novel N-methylated imidazolo-, pyrrolo-, and pyrazolo-pyrimidines as potent and selective mTOR inhibitorsBioorg Med Chem Lett201323185097510423932790
   PubMed Web of Science ®Google Scholar
• FinlayMRVButtarDCritchlowSESulfonyl-morpholino-pyrimidines: SAR and development of a novel class of selective mTOR kinase inhibitorBioorg Med Chem Lett201222124163416822607682
   PubMed Web of Science ®Google Scholar
• KumarAPurohitRComputational investigation of pathogenic nsSNPs in CEP63 proteinGene20125031758222555018
   PubMed Web of Science ®Google Scholar
• RajendranVSethumadhavanRDrug resistance mechanism of PncA in Mycobacterium tuberculosisJ Biomol Struct Dyn201432220922123383724
   PubMed Web of Science ®Google Scholar
• PurohitRRole of ELA region in auto-activation of mutant KIT receptor: a molecular dynamics simulation insightJ Biomol Struct Dyn20143271033104623782055
   PubMed Web of Science ®Google Scholar
• KumarAPurohitRUse of long term molecular dynamics simulation in predicting cancer associated SNPsPLoS Comput Biol2014104e100331824722014
   PubMed Web of Science ®Google Scholar
• NetzevaTIWorthAAldenbergTCurrent status of methods for defining the applicability domain of (quantitative) structure-activity relationships. The report and recommendations of ECVAM Workshop 52Altern Lab Anim200533215517316180989
   PubMed Web of Science ®Google Scholar
• WorthABassanAGallegosAThe Characterisation of (Quantitative) Structure-Activity Relationships: Preliminary GuidanceIspra, ItalyEuropean Commission, Joint Research Centre
   Google Scholar
• DarnagRMostapha MazouzELSchmitzerAVilleminDJaridACherqaouiDSupport vector machines: development of QSAR models for predicting anti-HIV-1 activity of TIBO derivativesEur J Med Chem20104541590159720110136
   PubMed Web of Science ®Google Scholar
• LakhliliWChevéGYasriAIbrahimiADetermination and validation of mTOR kinase-domain 3D structure by homology modelingOncoTargets Ther2015819231930
   Google Scholar
• MOE: Molecular Operating Environment2013 Available from: http://www.chemcomp.com/MOE-Molecular_Operating_Environment.htmAccessed August 15, 2013
   Google Scholar
• IrwinJJShoichetBK database on the InternetZINC – a free database of commercially available compounds for virtual screeningJ Chem Inf Model2005451177182 Available from: http://zinc.docking.org/Accessed July 1, 201215667143
   PubMed Web of Science ®Google Scholar
• DouguetD database on the Internete-LEA3D: a computational-aided drug design web serverNucleic Acids Res201038Suppl 2W615W621 Available from: http://chemoinfo.ipmc.cnrs.fr/lea.htmlAccessed July 1, 201220444867
   PubMed Web of Science ®Google Scholar
• AthanasiadisECourniaZSpyrouG database on the InternetChemBioServer: a web-based pipeline for filtering, clustering and visualization of chemical compounds used in drug discoveryBioinformatics2012282230023003 Available from: http://bioserver-3.bioacademy.gr/Bioserver/ChemBioServer/Accessed July 1, 201222962344
   PubMed Web of Science ®Google Scholar
• TrottOOlsonAJAutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJ Comput Chem201031245546119499576
   PubMed Web of Science ®Google Scholar
• MorrisGMHueyRLindstromWAutoDock4 and AutoDockTools4: automated docking with selective receptor flexibilityJ Comput Chem200930162785279119399780
   PubMed Web of Science ®Google Scholar
• MorrisGMHueyROlsonAJUsing AutoDock for ligand-receptor dockingCurr Protoc Bioinformatics2008 Chapter 8: Unit 8.14
   Google Scholar
• WangRLaiLWangSFurther development and validation of empirical scoring functions for structure-based binding affinity predictionJ Comput Aided Mol Des2002161112612197663
   PubMed Web of Science ®Google Scholar
• SeeligerDde GrootBLLigand docking and binding site analysis with PyMOL and autodock/vinaJ Comput Aided Mol Des201024541742220401516
   PubMed Web of Science ®Google Scholar
• ErtlPRohdeBSelzerPFast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport propertiesJ Med Chem200043203714371711020286
   PubMed Web of Science ®Google Scholar
• HallLHKierLBThe molecular connectivity chi indexes and kappa shape indexes in structure-property modelingLipkowitzKBBoydDBReviews in Computational ChemistryNew JerseyJohn Wiley & Sons, Inc1991367422
   Google Scholar
• BalabanATHighly discriminating distance-based topological indexChem Phys Lett1982895399404
   Web of Science ®Google Scholar
• WoldHEstimation of principal components and related models by iterative least squaresKrishnaiahPKMultivariate AnalysisNew York, NYAcademic Press1966391420
   Google Scholar
• GramaticaPPrinciples of QSAR models validation: internal and externalQSAR Comb Sci2007265694701
   Google Scholar
• DietrichSWDreyerNDHanschCBentleyDLConfidence interval estimators for parameters associated with quantitative structure-activity relationshipsJ Med Chem19802311120112057452669
   PubMed Web of Science ®Google Scholar
• RoyKMitraIKarSOjhaPKDasRNKabirHComparative studies on some metrics for external validation of QSPR modelsJ Chem Inf Model201252239640822201416
   PubMed Web of Science ®Google Scholar
• IrwinJJSterlingTMysingerMMBolstadESColemanRGZINC: a free tool to discover chemistry for biologyJ Chem Inf Model20125271757176822587354
   PubMed Web of Science ®Google Scholar
• ChenLWangLGuQXuJAn in silico protocol for identifying mTOR inhibitors from natural productsMol Divers201418484185225156384
   PubMed Web of Science ®Google Scholar
• KhanfarMATahaMOElaborate ligand-based modeling coupled with multiple linear regression and k nearest neighbor QSAR analyses unveiled new nanomolar mTOR inhibitorsJ Chem Inf Model201353102587261224050502
   PubMed Web of Science ®Google Scholar
• TropshaAGolbraikhAPredictive QSAR modeling workflow, model applicability domains, and virtual screeningCurr Pharm Des200713343494350418220786
   PubMed Web of Science ®Google Scholar
• Manoj KumarPKarthikeyanCHari Narayana MoorthyNSTrivediPQuantitative structure-activity relationships of selective antagonists of glucagon receptor using QuaSAR descriptorsChem Pharm Bull (Tokyo)200654111586159117077558
   PubMed Web of Science ®Google Scholar
• FriedmanJHTibshiraniRHastieTThe Elements of Statistical Learning: Data Mining, Inference, and Prediction2nd edNew YorkSpringer2002
   Google Scholar
• ThaiKMBuiQHTranTDHuynhTNPQSAR modeling on benzo[c] phenanthridine analogues as topoisomerase I inhibitors and anti-cancer agentsMolecules20121755690571222580401
   PubMed Web of Science ®Google Scholar
• LiaoSYQianLLuHLShenYZhengKCA combined 2D- and 3D-QSAR study on analogues of ARC-111 with antitumor activityQSAR Comb Sci2008276740749
   Google Scholar
• LipinskiCALombardoFDominyBWFeeneyPJExperimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdv Drug Deliv Rev2001461–332611259830
   PubMed Web of Science ®Google Scholar